Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment, and Monoclonal and Polyclonal Antibodies Research.
Long‐term outcomes of patients with conjunctival extranodal marginal zone lymphoma
Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation
Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma
Frontline brentuximab vedotin in breast implant‐associated anaplastic large‐cell lymphoma
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab
Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the CalDAG‐GEFI encoding gene
Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study
In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response
PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.
PubMed 2013cited by 102position: middle
Inhibition of HSP90 with AUY922 Induces Synergy in HER2-Amplified Trastuzumab-Resistant Breast and Gastric Cancer
Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer